Beneficial bacteria produce short-chain fatty acids (SCFAs) like butyrate, acetate, and propionate when they ferment dietary fiber
There are several injectable medications currently approved for weight loss
However, this primarily reflects a lack of systematic investigation rather than confirmed safety
Researchers found that the GLP-1 group did not have higher rates of gestational diabetes, severe maternal morbidity, or other adverse maternal outcomes, suggesting that the medication may have helped mitigate elevated risk factors
GLP-3 (RT) GLP1 / GIP / Glucagon Triple Agonist Also referenced as: Retatrutide LY3437943 GLP-1 / GIP / Glucagon Triple Receptor Agonist Triagonist Peptide Triple-Hormone-Receptor Agonist 99% Purity Guaranteed Full Panel COA Free Shipping At $125+ Shipping Protection Lab Results Heavy Metals Breakdown (ICP-MS) LOT ZQ-20260610-RT10 Batch RT10-655 Tested Jul 1, 2026 ILS Curated research on GLP-3 (RT) Jastreboff AM (2023)
But medication alone is never the full answer